This article first appeared on GuruFocus.

Masoval AS (OSL:MAS) is set to release its Q3 2025 earnings on Nov 18, 2025. The consensus estimate for Q3 2025 revenue is $0.51 billion, and the earnings are expected to come in at -$0.20 per share. The full year 2025's revenue is expected to be $2.66 billion and the earnings are expected to be -$0.73 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 6 Warning Signs with OSL:MAS.

Is OSL:MAS fairly valued? Test your thesis with our free DCF calculator.

Over the past 90 days, revenue estimates for Masoval AS (OSL:MAS) have increased from $2.49 billion to $2.66 billion for the full year 2025 and from $2.76 billion to $3.06 billion for 2026. Earnings estimates have declined from -$0.31 per share to -$0.73 per share for the full year 2025, while they have increased from $2.29 per share to $2.63 per share for 2026.

In the previous quarter ending on June 30, 2025, Masoval AS's (OSL:MAS) actual revenue was $0.69 billion, which missed analysts' revenue expectations of $0.73 billion by -5.56%. Masoval AS's (OSL:MAS) actual earnings were $0.86 per share, which beat analysts' earnings expectations of $0.27 per share by 218.52%. After releasing the results, Masoval AS (OSL:MAS) was down by -2.17% in one day.

Based on the one-year price targets offered by 3 analysts, the average target price for Masoval AS (OSL:MAS) is $29, with a high estimate of $31 and a low estimate of $26. The average target implies an upside of 23.40% from the current price of $23.50.

Based on GuruFocus estimates, the estimated GF Value for Masoval AS (OSL:MAS) in one year is $40.47, suggesting an upside of 72.21% from the current price of $23.50.

Based on the consensus recommendation from 4 brokerage firms, Masoval AS's (OSL:MAS) average brokerage recommendation is currently 1.5, indicating a \\"Buy\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.